CRP and Insulin resistance: Supplementation with the nonanimal CS resulted in larger reductions in (mean differences and 95% CI) weight (kg) −2.23 (−3.57; −0.89), BMI (kg/m2) −0.73 (−1.21; −0.25), WOMAC −8.83 (−14.62; −3.04), CRP (mg/dL) −0.33 (−0.54; −0.12), total cholesterol (mg/dL) −9.77 (−17.75; −1.78), Homeostatic Model Assessment of insulin resistance (HOMA-IR) −0.77 (−1.47; −0.07) and gamma-glutamyltransferase (GGT) (U/L) −3.91 (−7.50; −0.31)*.